Searched for
HIV SURGE
SBI Card likely to benefit from festival season and GST cuts: Amnish AggarwalIndian markets are currently experiencing significant activity across various sectors. Pharma companies like Glenmark, Dr Reddy's, and Lupi...- Donor aid cuts may undo years of progress in combating HIV: StudyUS President Trump's decision to suspend USAID programmes and fund cuts by other countries could lead to 10.8 million new HIV infections an...
- US foreign aid ban hits HIV-related local drug stocksLaurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of ...
- You’re at a higher risk of severe illness from HMPV virus if…The Human Metapneumovirus (HMPV) outbreak in China has raised global concern, with India reporting three cases. The Health Ministry has rea...
- HIV is back; there has been a 30% surge in 2 years; is it that fatal now?New HIV has been diagnosed among heterosexual men and women in England, which has surged over 30 per cent in the last two years. According ...
- Rising Syphilis cases in the US amidst funding shortagesNevada, for instance, witnessed a staggering 44% increase in congenital syphilis cases from 2021 to 2022. The state was poised to receive o...
- Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug DolutegravirThe company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of whic...
- Lupin shares hit 52-week high after launch of HIV drug Darunavir in USLupin's shares reached a 52-week high of INR 830.3 after it announced the launch of its Darunavir Tablets to market a generic equivalent of...
- New coronavirus variant a ‘serious concern’ in South AfricaThe new discovery, called B.1.1529 until a Greek letter is assigned, carries an unusually large number of mutations and is “clearly very di...
- COVID-19 pandemic could lead to HIV surge in West & Central Africa, says UNAIDS chiefAlthough human immunodeficiency virus (HIV) infection rates, and acquired immunodeficiency syndrome (AIDS)-related deaths have been on a st...
- How India can 'PrEP' better for fight against HIVIndia experienced a surge of HIV cases in the 1990s and early 2000s. According to the National Social Marketing Centre (NSMC), during 2001-...
- Emcure Pharma files DRHP for IPOPune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies, filed its draft red herring prospectus (DRHP) with the...
- Asymptomatic patients transmitting virus like a wildfire in IndiaThe threat of double and now a triple-mutant Indian strain, along with the deadly UK variant, are believed to be behind the latest surge ac...
- COVID-19 pandemic's long-term impact could lead to more new HIV infections, AIDS-related deaths: UNThe UNAIDS is calling on countries to make far greater investments in global pandemic responses and adopt a new set of bold, ambitious but ...
- Anthony Fauci cautiously optimistic: Countries need to pull back to contain the spread“We did not shut down entirely and that’s the reason why we went up. It had started to come down, and then we plateaued at a level that was...
- A 'Lancet' study says Covid-19 pandemic may lead to surge in HIV, malaria deaths; timely treatment can save livesCore services for HIV, TB, and malaria could largely mitigate the broader health impact of the pandemic.
- Covid-19: China stalls supplies, India faces anti-retroviral shortageAntiretrovirals - used for treating coronavirus - are manufactured by around five major pharma companies in India. The demand for such drug...
- Mapping the market: Fed relief lifts BSE M-cap by Rs 1L cr; Aurobindo, Sadbhav rallyThe BSE Sensex surged 266 points, or 0.93 per cent, to settle at 28,773. The Nifty50 could not kiss the 8,900 mark, but managed to climb 1....
- Matrix Labs hits upper circuit on delisting plansShares of Matrix Laboratories were in the limelight after its parent Mylan Inc said it plans to acquire the remaining 29 per cent in the In...
- Indian firms get lion's share in US anti-AIDS fundingAurobindo Pharma, Cipla and Ranbaxy, have received a lion's share of over 85 per cent in the US government's latest fiscal funding for AIDS...
Load More
